Results 121 to 130 of about 1,587 (177)

Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights. [PDF]

open access: yesOpen Respir Arch
López-Castro R   +6 more
europepmc   +1 more source

[PAPPS Expert Groups. Cancer prevention recommendations: Update 2022]. [PDF]

open access: yesAten Primaria, 2022
Marzo-Castillejo M   +4 more
europepmc   +1 more source

Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]

open access: yesRev Col Bras Cir, 2023
Vallejo JSA   +7 more
europepmc   +1 more source

Reprogramming the tumor microenvironment in mesothelioma: from immune suppression to therapeutic opportunity. [PDF]

open access: yesFront Immunol
Cerbone L   +16 more
europepmc   +1 more source

BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment. [PDF]

open access: yesInt J Mol Sci, 2019
Guazzelli A   +6 more
europepmc   +1 more source

Incidental finding of an ectopic b2 thymoma attached to the pericardium. [PDF]

open access: yesJ Surg Case Rep
Endara SA   +4 more
europepmc   +1 more source

Mesoteliomas pleurais malignos.

open access: yesActa Médica Portuguesa, 1986
L Carreiro   +4 more
openaire   +1 more source

[Gemcitabine-induced digital necrosis in a patient with cervical squamous cell carcinoma: case report and literature review]. [PDF]

open access: yesRev Colomb Obstet Ginecol
Guarín-Rivera S   +4 more
europepmc   +1 more source

O mesotelioma pleural maligno

open access: yesRevista do Grupo de Estudos do Cancro do Pulmão, 2022
openaire   +1 more source

Home - About - Disclaimer - Privacy